These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7251830)

  • 21. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use.
    Prentice B; Robinson BL
    Can Med Assoc J; 1979 Sep; 121(6):745-9. PubMed ID: 519613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1974 Jun; 5(6):571-7. PubMed ID: 15825407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R plasmids in gentamicin-tobramycin-carbenicillin-resistant nosocomial strains of Proteus rettgeri and Proteus morgani.
    Výmola M; Zahradnický J; Krcméry V; Trojanová M; Chaloupecký V
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(3):382-14. PubMed ID: 570994
    [No Abstract]   [Full Text] [Related]  

  • 24. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.
    Penner JL; Preston MA; Hennessy JN; Barton LJ; Goodbody MM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):218-21. PubMed ID: 6765415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital.
    Tumbarello M; Citton R; Spanu T; Sanguinetti M; Romano L; Fadda G; Cauda R
    J Antimicrob Chemother; 2004 Feb; 53(2):277-82. PubMed ID: 14688041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.
    Marengo PB; Chenoweth ME; Overturf GD; Wilkins J
    Antimicrob Agents Chemother; 1974 Dec; 6(6):821-4. PubMed ID: 4455126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kanamycin resistance in Providencia stuartii.
    McHale P; English L; Speekenbrink A; Keane C
    J Antimicrob Chemother; 1978 May; 4(3):273-8. PubMed ID: 670120
    [No Abstract]   [Full Text] [Related]  

  • 28. Application of O-serotyping in a study of Providencia rettgeri (Proteus rettgeri) isolated from human and nonhuman sources.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1979 Dec; 10(6):834-40. PubMed ID: 521481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transferable urease activity in Providencia stuartii.
    Grant RB; Penner JL; Hennessy JN; Jackowski BJ
    J Clin Microbiol; 1981 Mar; 13(3):561-5. PubMed ID: 7240389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteus infections in a general hospital. I. Biochemical characteristics and antibiotic susceptibility of the organisms. With special reference to proticine typing and the Dienes phenomenon.
    Adler JL; Burke JP; Martin DF; Finland M
    Ann Intern Med; 1971 Oct; 75(4):517-30. PubMed ID: 5209286
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective survey of fecal, urinary tract, and environmental colonization by Providencia stuartii in two geriatric wards.
    Hawkey PM; Penner JL; Potten MR; Stephens M; Barton LJ; Speller DC
    J Clin Microbiol; 1982 Sep; 16(3):422-6. PubMed ID: 7130358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of urine-grown cells of Providencia stuartii to antiseptics.
    Thomas B; Sykes L; Stickler DJ
    J Clin Pathol; 1978 Oct; 31(10):929-32. PubMed ID: 711901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UK31214, a new aminoglycoside and derivative of kanamycin B.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):298-301. PubMed ID: 6775590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual Enterobacteriaceae. "Proteus rettgeri" that "change" into Providencia stuartii.
    Farmer JJ; Hickman FW; Brenner DJ; Schreiber M; Rickenbach DG
    J Clin Microbiol; 1977 Oct; 6(4):373-8. PubMed ID: 334793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serological passage of bacteria of the genus Providencia isolated from patients with wound, urological and intestinal infections].
    Raginskaia VP; Lifshits MB; Baturo AP; Romanenko EE
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):44-7. PubMed ID: 6205523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gentamicin resistance in clinical strains of Enterobacteriaceae associated with reduced gentamicin uptake.
    Adwan K; Abu-Hasan N
    Folia Microbiol (Praha); 1998; 43(4):438-40. PubMed ID: 9821296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Providencia stuartii infections: a review of 117 cases over an eight year period.
    McHale PJ; Walker F; Scully B; English L; Keane CT
    J Hosp Infect; 1981 Jun; 2(2):155-65. PubMed ID: 6174578
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and drug resistance characteristics of
    Liu J; Wang R; Fang M
    J Int Med Res; 2020 Oct; 48(10):300060520962296. PubMed ID: 33081537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorhexidine resistance and the lipids of Providencia stuartii.
    Thomas B; Stickler DJ
    Microbios; 1979; 24(97-98):141-50. PubMed ID: 530092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three episodes of nosocomial urinary tract infections caused by one O-serotype of Providencia stuartii.
    Penner JL; Hinton NA; Hamilton LJ; Hennessy JN
    J Urol; 1981 May; 125(5):668-71. PubMed ID: 7230337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.